Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Colorectal Neoplasms and PTCH1[original query] |
---|
A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22. British journal of cancer 2011 Sep 105 (6): 870-5. Abulí A, Fernández-Rozadilla C, Giráldez M D, Muñoz J, Gonzalo V, Bessa X, Bujanda L, Reñé J M, Lanas A, García A M, Saló J, Argüello L, Vilella A, Carreño R, Jover R, Xicola R M, Llor X, Carvajal-Carmona L, Tomlinson I P M, Kerr D J, Houlston R S, Piqué J M, Carracedo A, Castells A, Andreu M, Ruiz-Ponte C, Castellví-Bel S, |
Downregulation of the hedgehog receptor PTCH1 in colorectal serrated adenocarcinomas is not caused by PTCH1 mutations. Virchows Archiv : an international journal of pathology 2011 Feb 458 (2): 213-9. Stefanius Karoliina, Kantola Tiina, Tuomisto Anne, Vahteristo Pia, Karttunen Tuomo J, Aaltonen Lauri A, Mäkinen Markus J, Karhu Au |
Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1. Genome medicine 2017 May 9 (1): 46. Sveen Anita, Johannessen Bjarne, Tengs Torstein, Danielsen Stine A, Eilertsen Ina A, Lind Guro E, Berg Kaja C G, Leithe Edward, Meza-Zepeda Leonardo A, Domingo Enric, Myklebost Ola, Kerr David, Tomlinson Ian, Nesbakken Arild, Skotheim Rolf I, Lothe Ragnhild |
Two novel colorectal cancer risk loci in the region on chromosome 9q22.32. Oncotarget 2018 Feb 9 (13): 11170-11179. Thutkawkorapin Jessada, Mahdessian Hovsep, Barber Tom, Picelli Simone, von Holst Susanna, Lundin Johanna, Valle Laura, Kontham Vinaykumar, Liu Tao, Nilsson Daniel, Jiao Xiang, Lindblom Anni |
Additional Biomarkers beyond RAS That Impact the Efficacy of Cetuximab plus Chemotherapy in mCRC: A Retrospective Biomarker Analysis. Journal of oncology 2018 2018 5072987. Zheng Peng, Liang Chunmin, Ren Li, Zhu Dexiang, Feng Qingyang, Chang Wenju, He Guodong, Ye Lechi, Chen Jingwen, Lin Qi, Yi Tuo, Ji Meiling, Niu Zhengchuan, Jian Mi, Wei Ye, Xu Jianm |
Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer. Pharmacological research 2020 6 159 105028. Lin Anqi, Zhang Hongman, Hu Xigang, Chen Xiaoting, Wu Gang, Luo Peng, Zhang Ji |
Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer. Journal of Cancer 2020 4 11 (13): 3827-3833. Li Weihua, Qiu Tian, Dong Lin, Zhang Fanshuang, Guo Lei, Ying Jianmi |
PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients. Cancer immunology, immunotherapy : CII 2021 May . Wang Yanni, Chen Huan, Jiao Xi, Wu Lihong, Yang Ying, Zhang Jiao, Wu Lijia, Liu Chang, Zhuo Na, Li Shuang, Gong Jifang, Li Jian, Zhang Xiaotian, Wang Xicheng, Peng Zhi, Qi Changsong, Wang Zhenghang, Li Jie, Li Yan, Lu Zhihao, Zhang Henghui, Shen L |
Application of Multigene Panel Testing in Patients With High Risk for Hereditary Colorectal Cancer: A Descriptive Report Focused on Genotype-Phenotype Correlation. Diseases of the colon and rectum 2021 12 65 (6): 793-803. Park Ji Soo, Park Jung Won, Shin Saeam, Lee Seung-Tae, Shin Sang Joon, Min Byung Soh, Park Soo Jung, Park Jae Jun, Cheon Jae Hee, Kim Won Ho, Kim Tae |
[Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2021 10 43 (10): 1088-1093. Tang X J, Yang M Y, Zhu L Z, Xu D, Yuan |
Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center. ESMO open 2022 11 7 (6): 100607. Poliani L, Greco L, Barile M, Dal Buono A, Bianchi P, Basso G, Giatti V, Genuardi M, Malesci A, Laghi L, |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: